Dec 11, 2023 / 01:00PM GMT
Operator
Yes, good morning, and welcome to Cogent Biosciences webcast. I will now turn the call over to Christi Waarich, Senior Director of Investor Relations.
Christi Waarich - Cogent Biosciences, Inc. - IR
Thank you, operator. For today's call, we'll review the summer and APEX data value embedded cancer in patients with non there in advanced systemic mastocytosis. These data were presented and released in the press release over the weekend and earlier this morning, you can find the press release in the Investors and Media section of our website at cogentco.com.
Before we get started, please be reminded that remarks made during this call may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans, clinical development time lines, including future presentations of clinical data financial projection.
While these forward-looking statements represent our views as of today, they should not be relied upon as representing our views in the
Cogent Biosciences Inc to Host ASH Investor Event Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
